Business
Re Fruitflow Licence
Re Fruitflow Licence.
About this update from Provexis Plc
[{"type":"text","content":"\n Provexis PLC\n01 November 2006\n\n1 November 2006\n\n PROVEXIS PLC\n ('Provexis')\n\n Fruitflow Licence Delay\n\nProvexis, the nutraceutical company that develops scientifically-proven\nfunctional and medical foods, announces that discussions for the licensing of\nits Fruitflow(R) bioactive food ingredient to a major international brand owner\nwill now extend into 2007, due to the extension of the technical development\ntimeline.\n\nFollowing the announcement in July of a one-year Exclusivity Agreement between\nProvexis and a major international brand owner, the parties have been working\nintensively on the development of an advanced format of the Fruitflow(R)\nbioactive ingredient, and its incorporation into a new branded product format.\n\nThe patented, scientifically-proven Fruitflow(R) bioactive food ingredient\nreduces blood platelet aggregation, a significant contributing factor to\nthrombosis, which can cause heart attack or stroke.\n\nCommenting on the news, Stephen Moon, CEO of Provexis said:\n\n'While the delay is disappointing, it is important to optimise the technical\nplatform in order to maximise future potential revenues from our patented and\nproven Fruitflow(R) technology. Our partner remains wholly committed, and the\njoint project development team is focussed fully on reaching a successful\nconclusion.'\n\n\nFor further information please contact:\n\nStephen Moon, CEO Tel: 020 8392 6634\nProvexis plc\n\nVictoria Geoghegan\nEmma Kent\nBell Pottinger Corporate & Financial Tel: 020 7861 3232\n\n\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n \n ","length":1807,"tagName":"div"}]